General Information of the Compound
Compound ID
CP0185141
Compound Name
1-Butyl-3-(p-methylphenylsulfonyl)urea
    Show/Hide
Synonyms
1-Butyl-3-(4-methylphenylsulfonyl)urea
1-Butyl-3-(p-methylphenylsulfonyl)urea
1-Butyl-3-(p-tolylsulfonyl)urea
1-Butyl-3-(para-tolylsulfonyl) urea
1-Butyl-3-tosylurea
1-butyl-3-(4-methylphenyl)sulfonylurea
1-p-Toluenesulfonyl-3-butylurea
3-(p-Tolyl-4-sulfonyl)-1-butylurea
3-(p-tolylsulfonyl)-1-butylurea
3-[p-Tolyl-4-sulfonyl]-1-butylurea
Aglicid
Apo-Tolbutamide
Apotex Brand of Tolbutamide
Arcosal
Arkozal
Artosin
Artozin
Aventis Brand of Tolbutamide
Beglucin
Berlin-Chemie Brand of Tolbutamide
BerlinChemie Brand of Tolbutamide
Butamid
Butamide
Butamide Brand of Tolbutamide
Butamidum
D 860
Diaben
Diabesan
Diabetamid
Diabetol
Diabuton
Diasulfon
Diaval
Dirastan
Dolipol
Drabet
Glyconon
HLS 831
Hoechst Brand of Tolbutamide
Ipoglicone
Mobenol
N-(4-Methylbenzenesulfonyl)-N'-butylurea
N-(4-Methylphenylsulfonyl)-N'-butylurea
N-(p-Tolylsulfonyl)-N'-butylcarbamide
N-(p-tolylsulfonyl)-N'-n-butylurea
N-4-(Methylbenzolsulfonyl)-n-butylurea
N-4-Methylbenzolsulfonyl-N-butylurea
N-Butyl-N'-(4-methylphenylsulfonyl)urea
N-Butyl-N'-(p-tolylsulfonyl)urea
N-Butyl-N'-p-toluenesulfonylurea
N-Butyl-N'-toluene-p-sulfonylurea
N-n-Butyl-N'-tosylurea
Novo-Butamide
Orabet
Oralin
Oramide
Orezan
Orinase
Orinase (TN)
Orinaz
Oterben
Pfizer Brand of Tolbutamide
Pramidex
R.A.N. Brand of Tolbutamide
Rastinon
Restinon
Sk-tolbutamide
T 0891
TOLBUTAMIDE USP
Tarasina
Tol-Tab
Tolbet;Tolbusal
Tolbutamid
Tolbutamid R.A.NTolbutamida
Tolbutamida [INN-Spanish]
Tolbutamide
Tolbutamide (JP15/USP/INN)
Tolbutamide Aventis Brand
Tolbutamide Butamide Brand
Tolbutamide Hoechst Brand
Tolbutamide Pfizer Brand
Tolbutamide [INN:BAN:JAN]
Tolbutamidum
Tolbutamidum [INN-Latin]
Tolbutone
Toluina
Tolumid
Toluran
Toluvan
Tolylsulfonylbutylurea
U 2043
Valdecasas Brand of Tolbutamide
Willbutamide
Yamanouchi Brand of Tolbutamide
    Show/Hide
Structure
Formula
C12H18N2O3S
Molecular Weight
270.354
Canonical SMILES
CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1
    Show/Hide
InChI
InChI=1S/C12H18N2O3S/c1-3-4-9-13-12(15)14-18(16,17)11-7-5-10(2)6-8-11/h5-8H,3-4,9H2,1-2H3,(H2,13,14,15)
    Show/Hide
InChIKey
JLRGJRBPOGGCBT-UHFFFAOYSA-N
CAS
100735-34-0
64-77-7
Physicochemical Property
logP
1.78302
Rotatable Bonds
5
Heavy Atom Count
18
Polar Areas
75.27
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
3
Complexity
18

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 5505
SID: 15197366
ChEMBL ID
CHEMBL782
DrugBank ID
DB01124
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT06109, Geminin
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000015 SW480 Homo sapiens (Human)  1
1
Potency ~ 1412.5 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( Tolbutamide )
Drug Name Tolbutamide
Company Pharmacia And Upjohn Co
Indication
Non-insulin dependent diabetes
Approved
Target(s)
ATP-binding cassette transporter C9 (ABCC9)
Blocker
ATP-binding cassette transporter C8 (ABCC8)
Blocker